The G20 Global Pharma Summit Series-Canada has placed a significant emphasis on the escalating issue of Antibiotic Resistance and its implications for Infectious Disease Control. This global health threat undermines our ability to control infectious diseases, making previously treatable conditions potentially deadly.
Antibiotic resistance occurs when bacteria change in response to the use of antibiotics, rendering them ineffective. The overuse and misuse of antibiotics are key factors contributing to antibiotic resistance. The summit has highlighted the urgent need for collaborative efforts in research and development of new antibiotics, vaccines, and diagnostic tools.
Moreover, the G20 summit has emphasized the importance of implementing robust national action plans, improving surveillance of antibiotic-resistant infections, and strengthening health systems. These measures are crucial in ensuring the sustainable use of antibiotics and mitigating the impact of antibiotic resistance on global health.